Renal medullary carcinoma is a rare type of cancer that starts in the renal ... Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait: ...

Renal Cell Carcinoma Unclassified With Medullary Phenotype in a Patient With Neurofibromatosis Type 2.

Some research suggests that the average survival rate for someone with renal medullary carcinoma (RMC) at the time of diagnosis is approximately 4 months. However, treatment may improve a person ...

Recent oncology breakthroughs showcase innovative treatments and approvals, enhancing patient outcomes in CLL, RCC, NSCLC, ...

Sickle cell disease changes CD8+ T-cell chromatin structure, affecting cancer immunotherapy response. ... improving immunotherapy effectiveness in renal medullary carcinoma.

Selpercatinib extended PFS compared with two approved multikinase inhibitors for treatment of RET-mutant medullary thyroid cancer, according to the agent’s manufacturer. Selpercatinib (Retevmo ...